The role of placental hormones and metabolites in modulating uterine circulation in physiological and pathological pregnancies
Open Access
- 19 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1637570
Abstract
The adaptation of the uterine circulation during pregnancy is fundamental to ensure an adequate supply of oxygen and nutrients to the fetus, and this process is largely orchestrated by placental hormones/metabolites. In this review, we comprehensively examine the role of placental hormones, growth factors, and proteins in mediating vascular remodeling, vasodilation, and angiogenesis within the uterine circulation under both physiological and pathological conditions. Key molecules such as estrogens, progesterone, relaxin, VEGF, PlGF, and PTHrP, among others, promote structural and functional adaptations of uterine arteries, reduce vascular resistance, and enhance uteroplacental blood flow. Additionally, we discuss the impact of placental dysfunction on the development of pregnancy-related disorders such as preeclampsia, intrauterine growth restriction, gestational diabetes mellitus, and placenta accreta spectrum conditions that share common features of impaired uterine vascular remodeling and altered placental secretome. Furthermore, we explore innovative therapeutic strategies that aim to restore placental and vascular function, including gene therapy, mesenchymal stem cell-based approaches, and targeted nanomedicine. Finally, we highlight the emerging role of placental biomarkers for early diagnosis and risk stratification of vascular complications in pregnancy. Understanding the intricate interplay between placental secretions and the maternal vasculature is critical to advancing the prevention, diagnosis, and treatment of pregnancy complications, ultimately improving maternal and fetal health outcomes.Keywords
This publication has 296 references indexed in Scilit:
- Determining the risk of gestational diabetes using machine learning: A study on first‐trimester PAPP‐A and β‐hCG dataInternational Journal of Gynecology & Obstetrics, 2025
- Advances in Lipid Nanoparticle‐Based Disease TreatmentChemMedChem, 2025
- Nanoparticle‐mediated transgene expression of insulin‐like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrationsMolecular Reproduction and Development, 2022
- Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020JAMA, 2022
- Lipid Nanoparticles for Drug DeliveryAdvanced NanoBiomed Research, 2021
- Gestational diabetes mellitus (GDM) and adverse pregnancy outcome in South Asia: A systematic reviewEndocrinology, Diabetes & Metabolism, 2021
- Effects of Serelaxin in Patients Admitted for Acute Heart Failure: A Meta-AnalysisEuropean Journal of Heart Failure, 2019
- Human chorionic gonadotrophin (hCG) for preventing miscarriageCochrane Database of Systematic Reviews, 2013
- Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery DopplerPrenatal Diagnosis, 2005
- Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cellsJournal of Cellular Physiology, 1992